Aurinia Pharmaceuticals Inc.
Clinical trials sponsored by Aurinia Pharmaceuticals Inc., explained in plain language.
-
Lupus kidney drug study in teens halted early
Disease control TerminatedThis study aimed to check the long-term safety of voclosporin, a drug for lupus nephritis, in adolescents and children. It planned to follow participants for up to 12 extra months after they finished a previous study. However, the study was stopped early and only enrolled 4 peopl…
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC
-
Kidney drug trial for young lupus patients halted early
Disease control TerminatedThis study tested whether adding the drug voclosporin to standard treatment could help control kidney inflammation in children and teenagers with lupus nephritis. Participants received either voclosporin or a placebo along with their usual medications for 24 weeks. The main goal …
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC